Skip to main content
DocGo Inc. (DCGO)
NASDAQ: DCGO · Real-Time Price · USD
4.250
+0.130 (3.16%)
At close: Nov 22, 2024, 4:00 PM
4.040
-0.210 (-4.94%)
After-hours: Nov 22, 2024, 4:19 PM EST

DocGo Revenue

DocGo had revenue of $138.68M in the quarter ending September 30, 2024, a decrease of -25.66%. This brings the company's revenue in the last twelve months to $694.97M, up 30.19% year-over-year. In the year 2023, DocGo had annual revenue of $624.29M with 41.72% growth.

Revenue (ttm)
$694.97M
Revenue Growth
+30.19%
P/S Ratio
0.63
Revenue / Employee
$166,899
Employees
4,164
Market Cap
433.71M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023624.29M183.77M41.72%
Dec 31, 2022440.52M121.80M38.21%
Dec 31, 2021318.72M224.63M238.74%
Dec 31, 202094.09M45.79M94.81%
Dec 31, 201948.30M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Revance Therapeutics 256.95M
Rigel Pharmaceuticals 157.37M
Quanterix 129.33M
Semler Scientific 58.94M
Sangamo Therapeutics 52.29M
Cartesian Therapeutics 47.94M
Alpha Teknova 36.35M
Taysha Gene Therapies 9.92M
Revenue Rankings

DCGO News

More News